 DALLAS and FORT WORTH, Texas, Jan. 04, 2021 GLOBE NEWSWIRE -- Neos Therapeutics, Inc. Nasdaq: NEOS, a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that Jerry McLaughlin, President and Chief Executive Officer, will participate in a pre-recorded presentation as part of the H.C. Wainwright Virtual BioConnect Conference. 